Grant Medical Foundation
Pune, Maharashtra 411001
0 studies enrolling now · 6 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Inflammation, Obesity, Overweight, Peripheral Arterial Disease, Type 1 Diabetes Mellitus
Studies at this site
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) — Completed
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Stopped early
- The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Completed